SOAT1 and cancer: In line with this, research has also shown that, besides its pro-cancer effects, active JAK/STAT signalling also suppresses antitumour immune responses within the TME, suggesting that inhibition of this pathway might lead to a dual anticancer effect through activation of local immunity and also that combination with immunotherapy might enhance treatment response.